Document Report Card
Basic Information
ID: ALA3392926
Title: Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning
Authors: Kaiser M, Mäser P, Tadoori LP, Ioset JR, Brun R.
Abstract: In this study, a set of 100 registered drugs with drug repositioning potential for neglected tropical diseases was assembled. The compound collection was systematically screened against protozoan parasites, namely T. b. rhodesiense, L. donovani, T. cruzi and P. falciparum. Several drugs and drug classes exhibited in vitro activity and selectivity against one of the protozoan parasites. The results offer opportunities for drug repurposing and the identified compound classes could also be a starting point for new drug discovery projects. See also publication: Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning. PLoS One. 2015 10(8): e0135556.